𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions

✍ Scribed by Suzanne A. Gronemeyer; James W. Langston; Soheil L. Hanna; James W. Langston Jr.

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
603 KB
Volume
2
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Magnetic susceptibility variation caused by calcium permits limited detection of intracranial calcificatios and/or their distinction from iron‐laden lesions with spin‐echo or gradient‐echo magnetic resonance (MR) techniques. The magnetic susceptibility sensitivity of phase imaging has been used to detect iron‐laden lesions. A new approach that combines the magnetic susceptibility sensitivity of both gradient‐echo and phase imaging to yield greater imaging sensitivity to calcium is presented. Two‐dimensional fast low‐angle shot (FLASH) gradient‐echo imaging with phase image reconstruction (gradient‐echo phase [GEP]) was used at 1.0 and 1.5 T. Twelve patients with computed tomography‐proved calcified intracranial lesions (≥200 HU) and seven patients with iron‐laden intracranial lesions having a characteristic appearance on T1‐and T2‐weighted and FLASH MR images were studied. The GEP imaging technique helped detect calcified intracranial lesions (≥200 HU) and helped distinguish them from iron‐laden lesions.

📜 SIMILAR VOLUMES

Superparamagnetic iron oxide: Detection
Superparamagnetic iron oxide: Detection of focal liver lesions at high-field-strength MR imaging
✍ Stephan H. Duda; Michael Laniado; Andreas F. Kopp; Eckart Grönewäller; Klaus P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 829 KB

## Abstract AMI‐25 was evaluated at 1.5 T as a superparamagnetic iron oxide contrast agent for the liver. Sixteen patients with up to five suspected focal liver lesions were examined with T1‐, proton‐density—, and T2‐weighted spin‐echo sequences before and after intravenous administration of AMI‐25

Gadobenate dimeglumine-enhanced magnetic
Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: Effect of dose on lesion detection and delineation
✍ Günther Schneider; Miles A. Kirchin; Gianpaolo Pirovano; Cesare Colosimo; Jordi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

## Abstract Seventy‐four patients with one to eight proven intraaxial metastatic lesions to the brain received a total gadobenate dimeglumine dose of 0.3 mmol/kg of body weight, administered as three sequential bolus injections of 0.1 mmol/kg, at 10‐minute intervals over a 20‐minute period. Quantit

Detection of acute and treated lesions o
Detection of acute and treated lesions of hepatosplenic candidiasis: Conparison of dynamic contrast-enhanced CT and MR Imaging
✍ Richard C. Semelka; J. Patrick Shoenut; Howard M. Greenberg; Eric J. Bow 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

## Abstract Dynamic contrast‐enhanced computed tomography (CT) was compared with 1.5‐T magnetic resonance (MR) imaging with FLASH (fast low‐angle shot), gadolinium‐enhanced FLASH (Gd‐FLASH), and T2‐weighted fat‐suppression (T2FS) sequences in 11 patients with hematologic malignancies, five with bio

Detection and characterization of focal
Detection and characterization of focal hepatic lesions: Mangafodipir vs. Superparamagnetic iron oxide-enhanced magnetic resonance imaging
✍ Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Young Taik Oh; Jae-Joon Chung; Jin S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

## Abstract ## Purpose To compare the mangafodipir‐enhanced magnetic resonance (MR) and superparamagnetic iron oxide (SPIO)‐enhanced images for their ability to detect and characterize focal hepatic lesions. ## Materials and Methods Unenhanced, mangafodipir‐enhanced, and SPIO‐enhanced hepatic MR